LNA-ANTIMIR

Chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and development

Pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseases

Scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and products